Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients
详细信息 查看全文
- 作者：Dong Ji ; Guo-Feng Chen ; Cheng Wang ; Yu-Dong Wang ; Qing Shao…
- 关键词：Direct ; acting antivirals ; Chronic hepatitis C ; Ribavirin ; free ; Genotype 1b
- 刊名：Hepatology International
- 出版年：2016
- 出版时间：September 2016
- 年：2016
- 卷：10
- 期：5
- 页码：789-798
- 全文大小：556 KB
- 刊物主题：Hepatology; Colorectal Surgery; Surgery;
- 出版者：Springer India
- ISSN：1936-0541
- 卷排序：10
文摘
BackgroundTreatment-experienced chronic hepatitis C (CHC) genotype (GT) 1b represents a major medical burden in China. We evaluate the efficacy, safety and cost-effectiveness of ribavirin (RBV)-free pan-oral direct-acting antivirals (DAAs) in treatment-experienced Chinese with GT1b CHC, including patients with cirrhosis.